Novavax (NVAX)
(Delayed Data from NSDQ)
$3.97 USD
+0.08 (2.06%)
Updated Apr 19, 2024 03:59 PM ET
After-Market: $3.97 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/14/2024
Time: -- |
3/2024 | $-1.04 | 8.30% |
Earnings Summary
For their last quarter, Novavax (NVAX) reported earnings of -$1.44 per share, missing the Zacks Consensus Estimate of -$0.49 per share. This reflects a negative earnings surprise of 193.88%. Look out for NVAX's next earnings release expected on May 14, 2024. For the next earning release, we expect the company to report earnings of -$1.04 per share, reflecting a year-over-year increase of 69.5%.
Earnings History
Price & Consensus
Zacks News for NVAX
J&J (JNJ) to Begin Pharma Q1 Earnings Season: What's in Store?
NVAX: What are Zacks experts saying now?
Zacks Private Portfolio Services